Sanofi
June 23, 2026
Theater 2
Type: Company Presentation
Focus Area:
Multiple Therapeutics
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries. For more information please visit our website www.sanofi.com.
Company HQ City:
Cambridge
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
1973
Lead Product in Development:
Amlitelimab — Anti-IL-33 receptor mAb for atopic dermatitis and asthma (Phase 3)
Frexalimab — Anti-CD40L mAb for multiple sclerosis and rare kidney diseases (Phase 2)
SAR441566 (Oral TNFR1si) — For inflammatory conditions
CEO
Belen Garijo
Development Phase of Lead Product
Multiple Products in Market
Exchange
Nasdaq
Ticker
SNY
When you expect your next catalyst update?
N/A
What is your next catalyst (value inflection) update?
N/A
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}